DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Holdings Lessened by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 39.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 731,662 shares of the medical instruments supplier’s stock after selling 479,659 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.37% of DENTSPLY SIRONA worth $13,887,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Heartland Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 29.4% during the 4th quarter. Heartland Advisors Inc. now owns 712,400 shares of the medical instruments supplier’s stock worth $13,521,000 after purchasing an additional 161,653 shares during the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA during the fourth quarter worth $45,730,000. Artisan Partners Limited Partnership raised its holdings in DENTSPLY SIRONA by 4.6% during the fourth quarter. Artisan Partners Limited Partnership now owns 2,177,981 shares of the medical instruments supplier’s stock valued at $41,338,000 after buying an additional 95,549 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 1,568 shares during the last quarter. Finally, Nuance Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after acquiring an additional 2,708,097 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Mizuho decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, Morgan Stanley dropped their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $13.58 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $12.54 and a twelve month high of $33.02. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market cap of $2.70 billion, a P/E ratio of -6.56, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The firm’s 50-day simple moving average is $17.14 and its 200-day simple moving average is $19.80.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.71%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.